Panama vs Palestine: Cause of death, by non-communicable diseases, male
Panama
61.2%
in 2021
Palestine
61.5%
in 2021
Panama rank
88th
Palestine rank
86th
Cause of death, by non-communicable diseases, male over time
- Panama
- Palestine
How they compare
Palestine currently reports 61.5% against 61.2% in Panama, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Panama ahead.
Panama ranks 88th and Palestine ranks 86th of 185 countries.
Across the 3 decades both report, Panama averaged higher in 1 and Palestine in 2.
Head to head by decade
| Decade | Panama | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.1% | 50.5% | 11.6% | Panama |
| 2010s | 69.1% | 72.7% | 3.6% | Palestine |
| 2020s | 60.2% | 66.0% | 5.9% | Palestine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Panama or Palestine?
- Palestine, at 61.5% against 61.2% in Panama as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Panama and Palestine?
- 0.3%, with Palestine ahead.
- How many years of comparable data are there for Panama and Palestine?
- 6 years are reported by both, from 2000 to 2021.
- How do Panama and Palestine rank globally for cause of death, by non-communicable diseases, male?
- Panama ranks 88th and Palestine ranks 86th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.